| The dynamic mechanical environment of the chondrocyte: a biphasic finite element model of cell-matrix interactions under cyclic compressive loading E Kim, F Guilak, MA Haider | 103 | 2008 |
| Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma I Smalley, E Kim, J Li, P Spence, CJ Wyatt, Z Eroglu, VK Sondak, ... EBioMedicine 48, 178-190, 2019 | 95 | 2019 |
| Postmortem proteomics to discover biomarkers for forensic PMI estimation KM Choi, A Zissler, E Kim, B Ehrenfellner, E Cho, S Lee, P Steinbacher, ... International journal of legal medicine 133, 899-908, 2019 | 79 | 2019 |
| Inhibition of autophagy enhances the effects of the AKT inhibitor MK‐2206 when combined with paclitaxel and carboplatin in BRAF wild‐type melanoma VW Rebecca, RR Massaro, IV Fedorenko, VK Sondak, ARA Anderson, ... Pigment cell & melanoma research 27 (3), 465-478, 2014 | 75 | 2014 |
| Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach E Kim, V Rebecca, IV Fedorenko, JL Messina, R Mathew, ... Cancer research 73 (23), 6874-6885, 2013 | 66 | 2013 |
| Correlation between fibrin network structure and mechanical properties: an experimental and computational analysis E Kim, OV Kim, KR Machlus, X Liu, T Kupaev, J Lioi, AS Wolberg, ... Soft Matter 7 (10), 4983-4992, 2011 | 63 | 2011 |
| Adaptive therapy for metastatic melanoma: Predictions from patient calibrated mathematical models E Kim, JS Brown, Z Eroglu, ARA Anderson Cancers 13 (4), 823, 2021 | 59 | 2021 |
| Cell signaling heterogeneity is modulated by both cell-intrinsic and-extrinsic mechanisms: An integrated approach to understanding targeted therapy E Kim, JY Kim, MA Smith, EB Haura, ARA Anderson PLoS biology 16 (3), e2002930, 2018 | 51 | 2018 |
| An axisymmetric boundary element model for determination of articular cartilage pericellular matrix properties in situ via inverse analysis of chondron deformation E Kim, F Guilak, MA Haider | 51 | 2010 |
| A survey of open questions in adaptive therapy: bridging mathematics and clinical translation J West, F Adler, J Gallaher, M Strobl, R Brady-Nicholls, JS Brown, ... elife, 2023 | 50 | 2023 |
| Phase i trials in melanoma: A framework to translate preclinical findings to the clinic E Kim, VW Rebecca, KSM Smalley, ARA Anderson European Journal of Cancer 67, 213-222, 2016 | 40 | 2016 |
| Synthetic gut microbiome: advances and challenges HA Mabwi, E Kim, DG Song, HS Yoon, CH Pan, EVG Komba, GP Ko, ... Computational and structural biotechnology journal 19, 363-371, 2021 | 38 | 2021 |
| Mathematical model of covid-19 transmission dynamics in South Korea: the impacts of travel restrictions, social distancing, and early detection BN Kim, E Kim, S Lee, C Oh Processes 8 (10), 1304, 2020 | 29 | 2020 |
| Activity-Based Protein Profiling Reveals Potential Dasatinib Targets in Gastric Cancer KM Choi, E Cho, G Bang, SJ Lee, B Kim, JH Kim, SG Park, EH Han, ... International journal of molecular sciences 21 (23), 9276, 2020 | 21 | 2020 |
| Bridging scales in cancer progression: mapping genotype to phenotype using neural networks P Gerlee, E Kim, ARA Anderson Seminars in cancer biology 30, 30-41, 2015 | 18 | 2015 |
| The impact of the spatial heterogeneity of resistant cells and fibroblasts on treatment response M MA, JY Kim, CH Pan, E Kim PLOS Computational Biology 18 (3), e1009919, 2022 | 15 | 2022 |
| How homeostasis limits keratinocyte evolution RO Schenck, E Kim, RR Bravo, J West, S Leedham, D Shibata, ... Proceedings of the National Academy of Sciences 119 (35), e2006487119, 2022 | 11 | 2022 |
| Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia E Kim, EJ Hwang, J Lee, DY Kim, JY Kim, DW Kim Neoplasia 32, 100817, 2022 | 8 | 2022 |
| Identification of Nucleolin as a Novel AEG-1-Interacting Protein in Breast Cancer via Interactome Profiling SJ Lee, KM Choi, G Bang, SG Park, EB Kim, JW Choi, YH Chung, J Kim, ... Cancers 13 (11), 2842, 2021 | 7 | 2021 |
| Prolonged MEK inhibition leads to acquired resistance and increased invasiveness in KRAS mutant gastric cancer KM Choi, E Cho, E Kim, JH Shin, M Kang, B Kim, EH Han, YH Chung, ... Biochemical and biophysical research communications 507 (1-4), 311-318, 2018 | 7 | 2018 |
Alexander R. A. AndersonChair of Integrated Mathematical Oncology, Moffitt Cancer Center確認したメール アドレス: moffitt.org